Levy AP - Search Results

1

Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR.

Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schömig A, Kastrati A. Koch W, et al. Among authors: levy ap. Clin Chem. 2002 Sep;48(9):1377-82. Clin Chem. 2002. PMID: 12194911

2

Haptoglobin phenotype and vascular complications in patients with diabetes.

Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K. Levy AP, et al. N Engl J Med. 2000 Sep 28;343(13):969-70. doi: 10.1056/NEJM200009283431313. N Engl J Med. 2000. PMID: 11012324 No abstract available.

3

Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.

Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel SR, Hir J, Grenadier E, Beyar R, Levy AP. Roguin A, et al. Among authors: levy ap. Am J Cardiol. 2001 Feb 1;87(3):330-2, A9. doi: 10.1016/s0002-9149(00)01368-0. Am J Cardiol. 2001. PMID: 11165970

4

Haptoglobin phenotype and coronary artery collaterals in diabetic patients.

Hochberg I, Roguin A, Nikolsky E, Chanderashekhar PV, Cohen S, Levy AP. Hochberg I, et al. Among authors: levy ap. Atherosclerosis. 2002 Apr;161(2):441-6. doi: 10.1016/s0021-9150(01)00657-8. Atherosclerosis. 2002. PMID: 11888529

5

Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.

Roguin A, Ribichini F, Ferrero V, Matullo G, Herer P, Wijns W, Levy AP. Roguin A, et al. Among authors: levy ap. Am J Cardiol. 2002 Apr 1;89(7):806-10. doi: 10.1016/s0002-9149(02)02189-6. Am J Cardiol. 2002. PMID: 11909563

6

Basic principles of angiogenesis for the interventional cardiologist.

Levy AP, Roguin A. Levy AP, et al. Int J Cardiovasc Intervent. 2000 Mar;3(1):13-19. doi: 10.1080/14628840050516262. Int J Cardiovasc Intervent. 2000. PMID: 12470382

7

Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Roguin A, et al. Among authors: levy ap. Diabetes Care. 2003 Sep;26(9):2628-31. doi: 10.2337/diacare.26.9.2628. Diabetes Care. 2003. PMID: 12941730

8

Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction.

Suleiman M, Kapeliovich MR, Roguin A, Aronson D, Meisel SR, Shochat M, Reisner SA, Hammerman H, Lotan R, Levy NS, Levy AP. Suleiman M, et al. Among authors: levy ap, levy ns. Diabetes Care. 2003 Sep;26(9):2699-700. doi: 10.2337/diacare.26.9.2699. Diabetes Care. 2003. PMID: 12941748 No abstract available.

9

ELISA for determination of the haptoglobin phenotype.

Levy NS, Levy AP. Levy NS, et al. Among authors: levy ap. Clin Chem. 2004 Nov;50(11):2148-50. doi: 10.1373/clinchem.2004.038547. Clin Chem. 2004. PMID: 15502083 No abstract available.

10

Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, Shochat M, Sulieman A, Reisner SA, Markiewicz W, Hammerman H, Lotan R, Levy NS, Levy AP. Suleiman M, et al. Among authors: levy ap, levy ns. Diabetes. 2005 Sep;54(9):2802-6. doi: 10.2337/diabetes.54.9.2802. Diabetes. 2005. PMID: 16123372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters